Orchestra BioMed Holdings, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
OBIO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
150 Union Square Drive, New Hope, PA

Insiders trading volume in the past year

Orchestra BioMed Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Medtronic plc 10%+ Owner $94.1M Dec 31, 2023
Rtw Investments, Lp 10%+ Owner $90.2M Apr 13, 2023
Roderick Wong Chief Executive Officer, Director, 10%+ Owner $45M Jan 24, 2023
HSAC 2 Holdings, LLC 10%+ Owner $8.78M Aug 5, 2024
David P. Hochman Chief Executive Officer and Chairperson, Director $7.6M +$46.5K +0.62% Aug 14, 2024
Darren Sherman President and Chief Operating Officer, Director $4.74M -$195K -3.95% Sep 9, 2024
William Reed Little Executive Vice President, Corporate Development & Strategy $2.16M +$28K +1.32% May 30, 2024
Eric S. Fain Director $548K -$30.7K -5.3% Sep 6, 2024
Jason Aryeh Director $479K Jun 20, 2024
Andrew Lawrence Taylor Chief Financial Officer $301K May 8, 2024
Michael Kaswan Chief Financial Officer $176K Apr 12, 2023
Pamela Ann Connealy Director $149K Jun 20, 2024
David Pacitti Director $123K Jun 20, 2024
Yuval Mika General Manager and Chief Technology Officer, Bioelectronic Therapies $96.7K May 8, 2024
John Prosper Mack Director $66.3K Aug 7, 2024
Eric A. Md Rose Director $52.8K Jun 20, 2024
Geoffrey Wade Smith Director $22.6K Jul 20, 2023
George Papandreou General Manager and Senior Vice President, Focal Therapies $21.6K May 8, 2024
Joshua Aiello Principal Accounting Officer $5.4K May 8, 2024
Perceptive Advisors Llc 10%+ Owner Jul 11, 2024

Recent Insider Transactions by Companies or Individuals for Orchestra BioMed Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.